BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10513807)

  • 1. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
    Brundula V; Rivas LJ; Blasini AM; París M; Salazar S; Stekman IL; Rodríguez MA
    Arthritis Rheum; 1999 Sep; 42(9):1908-16. PubMed ID: 10513807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
    Liossis SN; Ding XZ; Dennis GJ; Tsokos GC
    J Clin Invest; 1998 Apr; 101(7):1448-57. PubMed ID: 9525988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.
    Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC
    Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Warke VG; Tsokos GC
    Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients.
    Tsuzaka K; Takeuchi T; Onoda N; Pang M; Abe T
    J Autoimmun; 1998 Oct; 11(5):381-5. PubMed ID: 9802920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Juang YT; Krishnan S; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.
    Vassilopoulos D; Kovacs B; Tsokos GC
    J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T
    Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Kammer GM; Tsokos GC
    J Autoimmun; 2001 Mar; 16(2):133-42. PubMed ID: 11247639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
    Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
    Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
    Fujii Y; Fujii K; Tanaka Y
    Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.